Ketohexokinase

货号			产品名	纯度
A299396	现货	促	KHK-IN-1 HCl KHK-IN-1 HCl is a potent ketohexokinase (KHK) inhibitor with IC50 of 12 nM, interacts with Asp-27B in the ATP-binding region of KHK.	98%+
A2259954	现货	促	LY3522348 LY3522348是一种己酮糖激酶 (KHK) 抑制剂，主要用于研究与果糖代谢相关的疾病，如非酒精性脂肪肝炎 (NASH)、肾脏疾病和糖尿病。	98% 99.9+% ee
A1176587			KHK-IN-2	99+%
A366857			KHK-IN-1 KHK-IN-1 is a potent ketohexokinase (KHK) inhibitor with IC50 of 12 nM and interacts with Asp-27B in the ATP-binding region of KHK.	99+%
A1177842			PF-06835919 PF06835919 is a ketohexokinase (KHK) inhibitor used for treatment for non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and type 2 diabetes mellitus.	99+%
A2794551			LY3522348	99% 99.9+% ee

货号

产品名

纯度

A299396

现货

促

KHK-IN-1 HCl is a potent ketohexokinase (KHK) inhibitor with IC50 of 12 nM, interacts with Asp-27B in the ATP-binding region of KHK.

98%+

A2259954

现货

促

LY3522348

LY3522348是一种己酮糖激酶 (KHK) 抑制剂，主要用于研究与果糖代谢相关的疾病，如非酒精性脂肪肝炎 (NASH)、肾脏疾病和糖尿病。

98% 99.9+% ee

A1176587

KHK-IN-2

99+%

A366857

KHK-IN-1

KHK-IN-1 is a potent ketohexokinase (KHK) inhibitor with IC50 of 12 nM and interacts with Asp-27B in the ATP-binding region of KHK.

99+%

A1177842

PF-06835919

PF06835919 is a ketohexokinase (KHK) inhibitor used for treatment for non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and type 2 diabetes mellitus.

99+%

A2794551

LY3522348

99% 99.9+% ee